Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab.
Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
Jennifer E
JE
Yeh
Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Angiogenesis and Wound Healing Center, Brigham and Women's Hospital, Boston, Massachusetts.
William G
WG
Tsiaras
IBD, inflammatory bowel disease; PG, pyoderma gangrenosum; TNF-α, tumor necrosis factor alpha; inflammatory bowel disease; pyoderma gangrenosum; vedolizumab